High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection

Author(s):
Labots, M.; Buffart, T.E.; Haan, J.C.; Grieken, N.C.T. van; Tijssen, M.; Velde, C.J.H. van de (0000-0003-0104-1800); Grabsch, H.I.; Ylstra, B.; Carvalho, B.; Fijneman, R.J.A.; Verheul, H.M.W.; Meijer, G.A.
Published
2014
Publication type
Article / Letter to editor
Gastric cancerDNA copy number changesDrug target geneTreatment selectionPersonalized medicineDrug repositioning
Date issued
2014-02-28
Language
English
Is part of
Cellular Oncology (2014), Vol. 37, no. 1, p. 41-52
hdl
1887/108347
doi
10.1007/s13402-013-0162-4